Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recro Pharma

2.09
0.0000
Volume:- -
Turnover:296.93K
Market Cap:97.42M
PE:-0.91
High:2.09
Open:2.09
Low:2.09
Close:2.09
Loading ...

Is Recro Pharma (REPH) a Worthy Investment?

Insider Monkey
·
22 Mar 2022

Recro Pharma Inc Announces That It Is Changing Its Name To Societal Cdmo Inc

T-Reuters
·
21 Mar 2022

Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention

GlobeNewswire
·
26 Jan 2022

Do Options Traders Know Something About Recro Pharma (REPH) Stock We Don't?

Zacks
·
08 Dec 2021

Recro to Present at Stephens Annual Investment Conference

GlobeNewswire
·
02 Dec 2021

5 Penny Stocks Insiders Are Buying

Benzinga
·
16 Nov 2021

Recro Reports Third Quarter 2021 Financial Results

GlobeNewswire
·
10 Nov 2021

Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021

GlobeNewswire
·
03 Nov 2021

Recro Enters Into Master Commercial Supply and Services Agreement With Otsuka

GlobeNewswire
·
27 Oct 2021

Recro Secures Manufacturing Contract From NIH For Nasal Spray Analgesic

Benzinga
·
21 Oct 2021

Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic

GlobeNewswire
·
20 Oct 2021

Recro Reports Inducement Grants For New Staff

GlobeNewswire
·
06 Oct 2021

Here’s Why Taking Profits in Recro Pharma (REPH) Resulted to a Great Outcome for Artko Capital

Insider Monkey
·
25 Sep 2021

Recro Pharma (REPH) Moves to Buy: Rationale Behind the Upgrade

Zacks
·
17 Sep 2021

BRIEF-Recro And Biocorrx Expand Development And Manufacturing Relationship To Support Bicx104, An Implantable Naltrexone Pellet For The Treatment Of Opioid Use Disorder

Reuters
·
08 Sep 2021

Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

GlobeNewswire
·
08 Sep 2021

Recro to Host Webcast to Discuss Acquisition of San Diego-Based IRISYS

GlobeNewswire
·
17 Aug 2021